![Lei Meng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lei Meng
Director/Board Member at
Prellis Biologics, Inc.
Profile
Lei Meng is currently Director at Prellis Biologics, Inc. and Director at Dianthus Therapeutics OpCo, Inc. Former positions include Independent Director at Dianthus Therapeutics, Inc. from 2023 to 2024, Senior Manager at Forest Laboratories, Inc., Clinical Research Scientist at Merck & Co., Inc., Senior Consultant at McKinsey & Co., Inc., Analyst at Samlyn Capital LLC from 2008 to 2012, VP-Marketing Analytics & Business Development at Allergan UC from 2012 to 2021, and Senior Therapeutics Analyst at Avidity Partners Management LP from 2021 to 2024.
Education includes graduate degree from Harvard University in 1997, undergraduate degree from Barnard College in 1994, and MBA from INSEAD in 2003.
Lei Meng active positions
| Companies | Position | Start |
|---|---|---|
Prellis Biologics, Inc.
 Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Director/Board Member | - |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Director/Board Member | - |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Private Equity Investor | 01/09/2024 |
Former positions of Lei Meng
| Companies | Position | End |
|---|---|---|
Avidity Partners Management LP
 Avidity Partners Management LP Investment ManagersFinance Profile Unavailable. | Analyst-Equity | 01/08/2024 |
| DIANTHUS THERAPEUTICS, INC. | Director/Board Member | 23/05/2024 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/01/2021 |
Samlyn Capital LLC
 Samlyn Capital LLC Investment ManagersFinance Samlyn Capital uses a variety of investment strategies and has broad discretion in making investments for the funds. In general, the firm draws on numerous resources to generate ideas, including public financial statements, industry conferences, traditional Wall Street research and industry contacts, consultants and bankers. Research typically includes reviewing the prospectus of the company and conducting an analysis of a company’s reported earnings as well as financial statements and SEC filings. | Analyst-Equity | 01/01/2012 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | - |
Training of Lei Meng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Samlyn Capital LLC
Samlyn Capital LLC Investment ManagersFinance Samlyn Capital uses a variety of investment strategies and has broad discretion in making investments for the funds. In general, the firm draws on numerous resources to generate ideas, including public financial statements, industry conferences, traditional Wall Street research and industry contacts, consultants and bankers. Research typically includes reviewing the prospectus of the company and conducting an analysis of a company’s reported earnings as well as financial statements and SEC filings. | Finance |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Health Technology |
Avidity Partners Management LP
Avidity Partners Management LP Investment ManagersFinance Profile Unavailable. | Finance |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Lei Meng
